Cysteine
- Generic Name
- Cysteine
- Brand Names
- Elcys, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Nouress, Premasol, Primene, Procalamine 3, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C3H7NO2S
- CAS Number
- 52-90-4
- Unique Ingredient Identifier
- K848JZ4886
- Background
A thiol-containing non-essential amino acid that is oxidized to form cystine.
- Indication
For the prevention of liver damage and kidney damage associated with overdoses of acetaminophen
- Associated Therapies
- Total parenteral nutrition therapy, Amino acid supplementation
N-Acetyl Cysteine After Cervical Cerclage
- First Posted Date
- 2008-11-10
- Last Posted Date
- 2008-11-20
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 100
- Registration Number
- NCT00787813
- Locations
- 🇪🇬
Women's Health Center, Assiut, Egypt
An Open-Label Study of N-Acetyl Cysteine in Children With Autism
- First Posted Date
- 2008-05-12
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 24
- Registration Number
- NCT00676195
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
A Study of N-Acetyl Cysteine in Children With Autism
Phase 2
Completed
- Conditions
- Autistic Disorder
- Interventions
- Other: Placebo - sugar pill
- First Posted Date
- 2008-03-03
- Last Posted Date
- 2017-05-18
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 43
- Registration Number
- NCT00627705
- Locations
- 🇺🇸
Stanford University School of Medicine, Stanford, California, United States
N-Acetyl Cysteine in Trichotillomania
- First Posted Date
- 2006-07-20
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 50
- Registration Number
- NCT00354770
- Locations
- 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States
An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling
Phase 1
Completed
- Conditions
- Pathological Gambling
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2007-04-30
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 36
- Registration Number
- NCT00273702
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
Not Applicable
Completed
- Conditions
- Erythropoietic Protoporphyria
- First Posted Date
- 2000-02-25
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- FDA Office of Orphan Products Development
- Target Recruit Count
- 20
- Registration Number
- NCT00004831
Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
Phase 3
Completed
- Conditions
- Erythropoietic Protoporphyria
- First Posted Date
- 2000-02-25
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00004940
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath